Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Ugur Eskiocak, Ph.D
CEO at Voro Therapeutics
Speaker

Profile

Ugur Eskiocak, PhD is the Co-founder and CEO of Voro Therapeutics. Voro is developing oncology therapeutics through its category-defining, tumor-activated biologics platform. He has 20 years of experience in oncology research and drug development. He has advanced 6 immuno-oncology programs through IND-enabling studies and into the clinical trials in various leadership roles at Compass Therapeutics, Xilio Therapeutics, Takeda and Janux Therapeutics.

Agenda Sessions

  • Tumor-Activated PrimeBody Platform Unlocks the Safe and Effective Delivery of Potent Biologics Beyond the Reach of Conventional Approaches

    , 16:15
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Ugur at Antibody Engineering & Therapeutics Europe